Grinevich Iu A, Labunets I F
Vopr Onkol. 1987;33(6):46-52.
Thymic hormonal function, as assessed by thymic serum factor (FTS) titres, is reduced in melanoma. Correlation analysis was used to show dysfunctions of this gland to play an important role in the pathogenesis of changes occurring in cellular and humoral immune responses in tumor patients. The authors make a case for treatment with biologically active factors of the thymus or thymosin-like preparations as early as in T1 melanoma.
通过胸腺血清因子(FTS)滴度评估,黑色素瘤患者的胸腺激素功能降低。相关性分析表明,该腺体功能障碍在肿瘤患者细胞免疫和体液免疫反应发生变化的发病机制中起重要作用。作者主张早在T1期黑色素瘤时就用胸腺生物活性因子或类胸腺素制剂进行治疗。